Why Illumina Jumped 9.8% in November
Shares of the genomic sequencing specialist Illumina (NASDAQ: ILMN) rose nearly 10% in November, according to data from S&P Global Market Intelligence. However, there wasn't any company-specific news that can justify the move. Shareholders can likely chalk up the jump to continued enthusiasm for the company's breakout year.
Image source: Getty Images.
While there wasn't any big news released during the month, the company did have a few positive announcements to make, including:
Source: Fool.com
Illumina Inc. Aktie
106,24 €
-6,30 %
Die Community bevorzugt Illumina Inc., mit deutlich mehr Buy- (27) als Sell-Einschätzungen (4).
Ein Kursziel von 162 € für Illumina Inc. würde eine Steigerung von mehr als 50% gegenüber dem aktuellen Kurs von 106.24 € bedeuten.
